|
3GUC
Human Ubiquitin-activating Enzyme 5 in Complex with AMPPNP
Deposited 2009-03-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
57–329(273 aa)
Chain B
57–329(273 aa)
|
Not recorded
|
ZN ZINC ION × 2
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.2;287 K;1 M LITHIUM SULPHATE, 0.3 M AMMONIUM SULPHATE,0.1 M SODIUM CITRATE, PH 6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 287K
|
Resolution 2.25 Å
R-free 0.255
|
|
3H8V
Human Ubiquitin-activating Enzyme 5 in Complex with ATP
Deposited 2009-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
57–329(273 aa)
Fragment:residues 57-329
Chain B
57–329(273 aa)
Fragment:residues 57-329
|
Not recorded
|
ZN ZINC ION × 2
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.2;287 K;1 M LITHIUM SULPHATE, 0.3 M AMMONIUM SULPHATE, 0.1 M SODIUM CITRATE, PH 6.2 , VAPOR DIFFUSION, HANGING DROP, temperature 287K
|
Resolution 2.00 Å
R-free 0.224
|
|
5IAA
Crystal structure of human UBA5 in complex with UFM1
Deposited 2016-02-21
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
57–346(290 aa)
Fragment:UNP residues 57-346
Chain B
57–346(290 aa)
Fragment:UNP residues 57-346
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;8% Tascimate, pH 7.0 and 16% PEG3350
|
Resolution 1.85 Å
R-free 0.206
|
|
5L95
Crystal structure of human UBA5 in complex with UFM1 and AMP
Deposited 2016-06-09
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
68–346(279 aa)
Chain B
68–346(279 aa)
|
Not recorded
|
AMP ADENOSINE MONOPHOSPHATE × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1M HEPES pH7.5, 10% PEG 6000 and 5% 2-Methyl-2,4-pentanediol (MPD)
|
Resolution 2.10 Å
R-free 0.222
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
36–335(300 aa)
Chain B
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
36–335(300 aa)
Chain D
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
36–335(300 aa)
Chain F
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain G
36–335(300 aa)
Chain H
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain I
36–335(300 aa)
Chain J
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain K
36–335(300 aa)
Chain L
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 5
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain M
36–335(300 aa)
Chain N
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H78
E1 enzyme for ubiquitin like protein activation.
Deposited 2018-07-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain O
36–335(300 aa)
Chain P
36–335(300 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;293.13 K;0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.
|
Resolution 2.70 Å
R-free 0.242
|
|
6H8C
Structure of the human GABARAPL2 protein in complex with the UBA5 LIR motif
Deposited 2018-08-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
333–348(16 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 100;Pressure AMBIENT
NMR sample composition
0.6 mM [U-99% 13C; U-99% 15N] GABARAPL2, 1.0 mM No Ubiquitin-like modifier-activating enzyme 5 (UBA5) LIR motif, 50 mM No sodium phosphate, 100 mM No sodium chloride, 4.6 mM No sodium azide, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
1.0 mM No GABARAPL2, 0.6 mM [U-99% 13C; U-99% 15N] Ubiquitin-like modifier-activating enzyme 5 (UBA5) LIR motif, 50 mM No sodium phosphate, 100 mM No sodium chloride, 4.6 mM No sodium azide, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
7NVK
Crystal structure of UBA5 fragment fused to the N-terminus of UFC1
Deposited 2021-03-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain AAA
347–404(58 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;2% (v/v) Tacsimate pH 7.0, 20% PEG 3350, 0.1M HEPES pH 7.5, 6mM zinc sulfate
|
Resolution 2.65 Å
R-free 0.264
|
|
7NW1
Crystal structure of UFC1 in complex with UBA5
Deposited 2021-03-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain FFF
389–404(16 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 9
PEG DI(HYDROXYETHYL)ETHER × 2
PGE TRIETHYLENE GLYCOL × 1
GOL GLYCEROL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;35 mM citric acid, 65 mM bis-tris propane, 19% PEG3350, 100 mM lithium chloride
|
Resolution 1.95 Å
R-free 0.280
|
|
7NW1
Crystal structure of UFC1 in complex with UBA5
Deposited 2021-03-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain CCC
389–404(16 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;35 mM citric acid, 65 mM bis-tris propane, 19% PEG3350, 100 mM lithium chloride
|
Resolution 1.95 Å
R-free 0.280
|
|
7OVC
Structure of the human UFC1 protein in complex with the UBA5 C-terminal UFC1-binding motif.
Deposited 2021-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
381–404(24 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;298 K;Ionic strength (raw mmCIF value) 100;Pressure AMBIENT
NMR sample composition
1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|